Antimicrobial activities of Chaetomorpha antennina dichloromethane extract against isolated urinary tract infection pathogens by Maithili, S.S. & Ramanathan, G.
Maithili et al                                                                                                              Journal of Drug Delivery & Therapeutics. 2019; 9(4-s):18-21 
ISSN: 2250-1177                                                                                  [18]                                                                                 CODEN (USA): JDDTAO 
Available online on 15.08.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                     Research Article 
Antimicrobial activities of Chaetomorpha antennina dichloromethane 
extract against isolated urinary tract infection pathogens 
S.S. Maithili 1* and G. Ramanathan2 
1 Department of Microbiology, AVS College of Arts and Science, Ramalingapuram 636 106, Salem, Tamil Nadu, India. 
2 Department of Microbiology, Sri Paramakalyani College, Alwarkurichi 627 412, Tamil Nadu, India.  
 
ABSTRACT 
During the treatment of infectious diseases, upon repeated administration of an antibiotic, most microbial pathogens generate resistance to that 
antibiotic. Multiple drug resistance is also a widespread problem. Thus, it is the need of the hour to identify alternative a ntibacterial drugs. 
Seaweeds are one of the major repositories of numerous pharmacologically active secondary metabolites. The goal of this investigation is to 
evaluate the antimicrobial activity of Chaetomorpha antennina dichloromethane (DCM) extract against isolated urinary tract infection 
pathogens from urinary tract infection (UTI) infected patients. Antimicrobial activity, minimum inhibitory concentrations (MIC), minimum 
bactericidal or candicidal concentration (MBC/MCC) and biofilm inhibition activity of C. antennina extract was observed against the 7 isolated 
microbial strains: Enterococcus avium, Enterobacter cloacae, Staphylococcus hominis, Staphylococcus epidermidis, Pseudomonas aeruginosa, 
Proteus mirabilis, and Escherichia coli and Candida albicans (yeast). All isolated strains from UTI infected patients were later sequenced, 
identified and submitted in PubMed. The crude DCM extract of C. antennina showed remarkable inhibitory effects ranging between 2mm and 
9mm, and its activity was recorded in the following order of E. coli >E. avium> E. cloacae and S. hominis >S. epidermis > P. aeruginosa > P. 
mirabilis > C. albicans. The MIC ranged between 500 to 750µg/ml, and the MBC was recorded in the range of 750 to 1000µg/ml. The crude DCM 
extract of C. antennina was also observed to have biofilm inhibitory activity at different concentrations against isolated UTI pathogens. This 
investigation elucidates that C. antennina DCM extract possesses antimicrobial activity against isolated UTI pathogens.  
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1.  INTRODUCTION 
Urinary tract infection (UTI) is the condition where 
pathogenic bacteria invade the urethra and bladder and 
obstruct urine flow by causing inflammation, intolerable 
pain, and cloudy urine, along with nocturia and haematuria 
[1]. UTIs are one of the common bacterial infections that 
affect more than 150 million people per year worldwide, 
causing morbidity in infant boys, old men, and females of all 
ages [2]. The causative agents for UTIs are Gram-negative 
and/or Gram-positive bacteria as well as certain fungi. The 
most commonly prevailing infectious agent for UTIs is 
uropathogenic Escherichia coli (UPEC), followed by Klebsiella 
pneumonia, Staphylococcus saprophyticus, Enterococcus 
faecalis, group B Streptococcus, Proteus mirabilis, 
Pseudomonas aeruginosa, Staphylococcus aureus, 
and Candida spp [1, 2]. Antibiotics such as trimethoprim, 
sulphamethoxazole, and ciprofloxacin are among the most 
commonly recommended therapeutics for UTIs [3]. 
However, the rise of antibiotic resistance and high 
recurrence rates of such common infections leave a great 
impact on our society [2].  Thus, to combat antibiotic 
resistance, it is very important to identify safer and effective 
alternatives to treat UTIs. For centuries plants have been 
used around the world as herbal drugs and remedies for 
various diseases and infections [4]. 
Seaweeds are a great source of pharmaceutically important 
bioactive secondary metabolites that exhibit broad spectrum 
of various biological activities [5, 6, and 7]. Several seaweeds 
around the world, growing in varying habitats, have been 
explored extensively to isolate drugs or biologically active 
secondary metabolites. Chaetomorpha antennina (Bory) 
Kutzing is a genus of green algae in the family 
Cladophoraceae. The algae belonging to this genus have 
cylindrical cells with macroscopic filaments, characterized 
by unbranched filaments, which make them very distinctive 
from its closest relatives that are branched species under the 
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genus Cladophora. C. antennina have been reported to have 
various biological activities like antibacterial activity [8], 
antiplasmodial activity [9], antioxidant activity [10] etc.. 
Hence, the present investigation aims to determine the 
antimicrobial activity of the C. antennina extract against 
isolated UTI bacterial pathogens. 
2. MATERIALS AND METHODS  
Collection, identification and extraction of secondary 
metabolites from Indian marine green seaweeds 
Young and healthy green seaweeds were collected from 
Kanyakumari coastal area that lies between 77°05' and 
77°36' east longitude and 8°05' and 8°19' north latitude. The 
collected seaweed species were identified upto species level 
as C. antennina with the help of key identification reference 
described by Meshwarai [11]. Further, the seaweed was 
taxonomically identified as C. antennina by Dr. G.V.S. Murthy, 
Joint Director, Botanical Survey of India (BSI), Tamil Nadu 
Agricultural University Campus, Coimbatore, and the 
voucher specimen was deposited with registration number 
BSI/SRC/9/28/2015-16/91. Later, the voucher specimen of 
the seaweed C. antennina was stored in the Department of 
Microbiology, Sri Paramakalyani College, Alwarkurichi 627 
412, Tamil Nadu, India, for future references. 
The identified green seaweeds (C. antennina) were collected 
and rinsed with seawater, further rinsed with tap water to 
remove adhering particles and finally dried under shaded 
conditions (35°C to 37°C). The dried seaweeds were 
powered using mechanical blender. 100 g of dry seaweed 
powder were taken separately in a new screw cap bottle, 
and then soaked separately with 500 ml of dichloromethane 
(DCM) for 7days at 30ºC (cold extraction). After the 7 days 
period, the coloured mixture was filtered through cotton 
cheesecloth and finally filtered through Whatman No. 1 filter 
paper.  The filtrate was then concentrated using vacuum 
rotary evaporator. The final crude extract was weighted and 
stored in a screw capped glass bottle at 4ºC.  
2.1 Phytochemical screening: 
The C. antennina DCM extract was analyzed for preliminary 
phytochemical screening such as alkaloids, tannins (ferric 
chloride test), saponins, glycosides, flavonoids, terpenoids, 
triterpenoids, phenol, steroids, protein and sugars following 
the standard protocols [12]. 
2.2 Selection of pathogenic bacterial strains 
Urinary Tract Infective (UTI) clinical microbial pathogenic 
seven strains: S. hominis, S. epidermidis, K. pneumonia, E. 
cloacae, E. coli, E. avium, P. aeruginosa and C.  albicans, were 
isolated and all the UTI pathogenic strains were identified 
upto species level through molecular taxonomy 16S rRNA 
sequencing method and collected sequence were submitted 
to NCBI database and the obtained Accession numbers for all 
seven strains were MG907042, MG911002, MH908781, 
MG913261,  MG913260, MG913259, MG907041 and 
MG913256, respectively.  
2.3. Antimicrobial properties of seaweed C. antennina 
crude extract 
The agar well diffusion method was adopted for determining 
the antimicrobial activities of the C. antennina green 
seaweeds crude extract against the seven selected UTI 
pathogens. In brief, 12hrs cultures of the selected pathogenic 
bacterial strains were individually inoculated in Nutrient 
Broth (NB) and Candida albicans (yeast) was individually 
inoculated in Sabouraud’s Dextrose Broth (SDB). They were 
further incubated for 12–48 h before being used for 
antibacterial and antifungal assay. Then 30 ml of sterilized 
Muller Hinton Agar (MHA) for antibacterial and Sabouraud’s 
Dextrose Agar plates (SDA) were prepared and dispensed 
into Petri plates. After the solidification, wells with 6 mm 
diameter were punched in the MHA and SDA plates using 
sterile cork borer, and the test pathogenic bacteria (1×108 
cells/ml) and C. albicans (1×107 cells/ml) strains were 
spread over the surface of respective agar plates using 
sterile swabs. Thereafter experimental wells were loaded 
with 100 ml DMSO containing 750 mg/ml of crude extracts, 
Rifampicin (50 mg/ml) and Flucona-zole (75 mg/ml) were 
used as positive control, while DMSO was used as negative 
control. Then all the plates were incubated for about 24 h at 
a temperature of 37±2 °C for bacterial strains and 30±2 °C 
for 72–96 h for C, Candida strains. The assay was carried out 
in triplicates. The inhibition level or zone was measured 
from the edge of the well to the clear zone in millimeter 
(mm).   
2.4. Determination of MIC, MBC and minimum candicidal 
concentration (MCC) of crude C. antennina DCM seaweed 
extract 
Minimum inhibitory concentration (MIC) of DCM crude 
extract of C. antennina was performed through micro broth 
dilution method in 96 well microtiter plate (Poly propylene 
plate) as described by Eloff [13] and Sharma and Kumar 
[14]. The different concentrations of crude extracts (250 to 
1500 µg/ml) were prepared for bacterial strains and solvent 
was evaporated. Thereafter, 100 μl of bacterial (1×108 
CFU/ml) and fungal spores (1×107 cell/ml) suspension was 
added to each well. Only bacterial or fungal spores 
suspensions were used as negative control, while broth 
containing standard drug was used as positive control. The 
96 well microtiter plates were incubated at temperature of 
37°C for 24 h for bacterial strains and 48 h for fungal spores. 
The assay was done in triplicates. The MIC values were the 
lowest concentration of the seaweed extract that showed no 
visible turbidity after the incubation period. The MBC or 
MCC was determined by streaking each well contain a 
loopful of inoculums in a nutrient agar plates. The growth 
and least concentration of extract that showed no visible 
growth on sub culturing was taken as MBC or MFC values 
[15]. 
2.5 Antibiofilm properties of C. antennina DCM extract 
against UTI pathogens 
The effect of biofilm inhibitory effects was evaluated in (96-
well polystyrene flat-bottom) micro well plate method as 
described by CLSI [16]. Briefly, Different concentrations of 
test extract such as 250, 500, 750, 1000, 1250 and 
1500µg/ml were prepared in fresh Trypticase Soya Yeast 
broth (TSY). A final concentration 1 x 106 CFU/mL of test 
bacterial inoculusm was aliquoted into each well of 
microplate and cultured in presence of different 
concentrations (250-1500µg/ml) of the seaweed extract. 
Wells that contained medium and without extracts or only 
with DCM were used as controls. All the plates were 
incubated at a temperature of 37 °C for around 24 h for 
bacteria and 48 h for fungi/yeast. After incubation, culture 
broth was removed and each well was washed thoroughly 
with sterile distilled water to remove free floating cells. 
Thereafter plates were air dried for 30 min and the biofilm 
formed was stained with 0.5% crystal violet for 15 min at 
room temperature. After that, the excess of crystal violet 
strain was removed through 50% ethanol. Finally, the dye 
bound to the cells in each well was solubilized by the 
addition of 200 μl of 95% ethanol. After 15 min of 
incubation, the absorbance was then measured using a 
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microplate reader at 570 nm wavelength. The percentage 
biofilm inhibition was determined using the formula: 
Biofilm inhibition (%) = OD of the test - OD of the Negative 
Control / OD of the test samples 
2.6 In situ visualization of biofilm Architecture on crude 
extract of C. antennina 
In situ visualization of biofilm architecture was assessed in 
the crude DCM extract of C. antennina against predominate 
biofilm inhibitory effect rendering bacterial pathogens  S. 
hominis, P. mirabilis and C. albicans. Briefly, cell suspension 
at a final density of 1×106 CFU/mL was treated with 
different concentrations of crude DCM extract of C. 
antennina in a 24-well micro plate containing sterile 
rectangular glass slides (1×1 mm). After incubating at 37 °C 
for 24 h for bacteria and 48 h for fungi/yeast, the slides were 
washed thrice with PBS (0.01 M, pH 7.2) and stained with 
0.4% crystal violet solution for 5 min. Following staining, the 
slides were washed with sterilized water to remove the 
excess stain and air dried. The stained biofilm were 
observed in situ using a light microscope (Nikon Eclipse 
E200, Japan) at 400X magnification and images were 
captured using a phase contrast fluorescence microscopy 
using a digital camera [17]. 
2.7 Statistical analysis 
The data acquired in the present investigation were 
analyzed by Mean± SD and One way and Two way-ANOVA 
by using computer software SPSS version 16 at p<0.05 and, 
Probit analysis by using EPA software. 
3. RESULTS AND DISCUSSION 
Antimicrobial drug resistance is the foremost problem faced 
all over the world against the present antibiotic therapy 
used in treating infectious diseases [18, 19]. Various 
research activities have been focused on seaweeds for 
isolating and developing newer antimicrobial agents. During 
the past four decades many novel bioactive compounds have 
been isolated from marine organisms [7, 19]. Since seaweeds 
have been known to show promising antimicrobial action, 
the present investigation was aimed to observe the 
antimicrobial activities from C. antennina against isolated 
UTI pathogens. 
The preliminary phytochemical screening of the DCM crude 
extract of C. antennina showed the presence of alkaloid, 
flavonoids, tannins, glyceroids, terpenoids, phenols and 
sterols. Previously, Sivakumar and Safhi [19], Subathraa and 
Poonguzhali [20] and Abhishek et al. [21] reported that the 
presence of various phytochemical in the crude extracts of C. 
antennina such as carbohydrates, proteins, amino acids, 
alkaloid, flavonoids, tannins, terpenoids, glyceroids, phenols 
and sterols.  
In disc diffusion method, the zones of inhibition were 
observed around the wells indicating antibacterial activities. 
The present results depicted antimicrobial properties of C. 
antennina DCM extract with a maximum inhibition zone of 
9.17±1.041 mm that was recorded against C. albicans and 
the minimum zone of inhibition of 2.17±0.764 mm that was 
observed against to E. avium, whereas other UTI pathogens 
were observed to show only moderate inhibition zone 
against C. antennina DCM extract (Table 2). Thus, the results 
indicate that DCM extract of C. antennina have the potential 
to control the UTI pathogens. The results of this 
investigation was supported by Sivakumar and Safhi [19], 
who have reported antibacterial activity of petroleum ether 
extract of Chaetomorpha antennina against Staphylococcus 
aureus, Bacillus cereus, Bacillus subtilis, Klebsiella 
pneumoniae, Escherichia coli and Pseudomonas aeruginosa, 
with prominent zone of inhibition recorded as 7.3 ± 0.8 mm 
for S. aureus, 8 ± 0.6 mm for E. coli and 7.3 ± 1 mm for P. 
aeruginosa. This study outcome was also supported by Lima-
Filho et al. [22], who have earlier reported that the DCM 
extracts of Chaetomorpha species have growth inhibitory 
effect against Salmonella sp., Salmonella pullorum, 
Salmonella enteric subspecies diarizonae, Salmonella 
enetrica subspecies houtenae and M. Morganii with 
inhibition zone ranging from 10mm to 17mm. Additionally, 
Latha and Hemalatha [23] reported that the chloroform 
extract of C. antennina showed the moderate zone of 
inhibition ranging between 9 and 11 mm against the S. 
aureus, E. coli followed by P. aeruginosa. The above results 
may be due to the presence of pharmacologically active 
secondary metabolites in C. antennina DCM extract that 
possess antibacterial and anticandidal activities. 
The MIC is the lowest concentration of antibiotics that 
inhibits the visible bacterial growth after overnight 
incubation using defined cut-off values for experimentally 
determined MICs [24]. The MBC or MCC/MFC is 
complementary to the MIC. The MIC test demonstrates the 
lowest level of antimicrobial agent that greatly inhibits 
growth, whereas the MBC demonstrates the lowest level of 
antimicrobial agent resulting in microbial death. In the 
present investigation, MIC, MBC and MCC of crude DCM 
extract of C. antennina were tested against isolated Urinary 
tract Infective (UTI) microbial pathogens and the minimum 
concentration for inhibition of bacterial and candida growth 
of UTI pathogens were recorded and the result are listed in 
Table 3. From the above results, it was observed that the 
tested UTI pathogens such as S. hominis, S. epidermidis, P. 
mirabilis, E. avium, P. aeruginosa, C.  albicans showed MIC 
value of 500 µg/ ml and MBC/MCC value of 1000 µg / ml 
(Table 3). Similar findings were reported by Erturk and Tas, 
[25], who have reported that the extracts of all marine algae 
showed significant antimicrobial activity against pathogens 
like S. aureus and S. typhimurium. Additionally, there have 
been previous reports stating that brown, green and red 
algae have compounds with antiviral, cytostatic, antifungal, 
antihelminthic, and antibacterial activities [20]. 
Furthermore, Sivakumar and Safhi [19] reported 
antibacterial activity of petroleum ether extract of 
Chaetomorpha antennina. The above results (MIC, MBC and 
MCC) observed may be due to the presence of bioactive 
secondary metabolites in C. antennina DCM extract that have 
antibacterial and anticandidal activities.  
The inhibition of biofilm formation is considered as one of 
the major drug targets for the treatment of numerous 
bacterial as well as fungal infections. Extensive studies on 
the development of drugs with antibioflim activities have 
been undertaken [26]. The antibiofilm properties was 
assessed for different C. antennina DCM extract 
concentrations (500, 750, 1000, 1250 and 1500 µg/ml) at 
p>0.05 significance and the results showed the presence of 
excellent biofilm inhibition effects against the isolated UTI 
pathogens and it ranged from 8 to 91% (Fig 1). The biofilm 
inhibition was found to be concentration dependent, and it 
increased as the concentration of C. antennina DCM extract 
increased. Moreover, the effective MIC, biofilm inhibitory 
concentration (BIC) and MBC, test concentrations of C. 
antennina extracts was documented for S. hominis, P. 
mirabilis and C. albicans by using light microscope and 
documenting any changes in the biofilm architecture, surface 
area colonization and thickness, and the following order of 
biofilm inhibition was observed: C. albicans>S. hominis> P. 
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mirabilis. From the results of light microscope 
photomicrographs, we could confirm the reduction in 
bacterial and Candida biofilms, architectural changes in the 
structural morphology of the three selected biofilms and we 
also observed very less adherence onto the glass pieces at 
higher concentrations (1250 to 1500 µg/ml) of C. antennina 
DCM extract (Fig. 2). Similar results were reported by 
Murugan et al. [27] who observed biofilm inhibitory activity 
of C. antennina diethyl ether, chloroform, acetone and 
methanol extracts. Moreover, seaweed extracts have been 
previously reported to have biofilm inhibition effect on C. 
albicans [28]. The presence of varios bioactive secondary 
metabolites in the C. antennina DCM extract may be the 
reason behind the antibioflim activity against S. hominis, P. 
mirabilis and C. albicans. Thus, all the results collectively 
indicate that the C. antennina crude DCM extract possess 
excellent antimicrobial activity against the isolated UTI 
pathogens. 
4. CONCLUSION 
The current study reveals the bioactive potential of C. 
antennina crude DCM extract and explores its bioactive 
potentials in the development of valuable antimicrobial and 
antibioflim therapeutics, which are both economical, 
naturally available and may be comparatively safer 
alternatives to commercially available drugs. Further studies 
are needed to investigate and study the individual secondary 
metabolites from C. antennina that are responsible for the 
antimicrobial and bioflim inhibition activities.  
5. ACKNOWLEDGEMENT 
Authors are thankful to the Principal and the management of 
Sri Paramakalyani College, Alwarkurichi 627 412, Tamil 
Nadu, India, for   providing   the necessary facilities for 
research work. 
REFERENCES 
1. Mishra MP, Rath S, Swain SS, Ghosh G, Das D, Padhy RN. In 
vitro antibacterial activity of crude extracts of 9 selected 
medicinal plants against UTI causing MDR bacteria. J King 
Saud Univ Sci. 2017; 29: 84–95.  
2. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ.  Urinary 
tract infections: epidemiology, mechanisms of infection and 
treatment options. Nat Rev Microbiol. 2015; 13: 269–84. 
3. Foxman B.  The epidemiology of urinary tract infection. Nat 
Rev Urol.2010; 7: 653–60. 
4. Sharma A, Chandraker S, Patel VK, Ramteke P. Antibacterial 
Activity of Medicinal Plants against Pathogens causing 
Complicated Urinary Tract Infections. Indian J Pharm Sci. 
2009; 71: 136–139. 
5. Khotimchenko SV, Vaskovsky VE and Titlyanova TV. Fatty 
acids of marine algae from the Pacific coast of North 
California. Botanica Marina. 2002; 45 (1); 17-22. 
6. Vijayan SR, Santhiyagu P, Ramasamy R, Arivalagan P, Kumar 
G, Ethiraj K. and Ramaswamy BR. Seaweeds: A resource for 
marine bionanotechnology. Enzyme and microbial technology, 
2016: 95, pp.45-57. 
7. El Shafay SM, Ali SS and El-Sheekh MM. Antimicrobial activity 
of some seaweeds species from Red sea, against multidrug 
resistant bacteria. The Egyptian Journal of Aquatic 
Research, 2016; 42 (1); 65-74. 
8. Choudhury S, Sree A, Mukherjee SC, Pattnaik P, Bapuji M. In 
vitro antibacterial activity of extracts of selected marine algae 
and mangroves against fish pathogens. Asian Fisheries Science, 
2005; 18(3/4): 285-294.  
9. Ravikumar S, Ramanathan G, Inbaneson SJ, Ramu A. 
Antiplasmodial activity of two marine polyherbal 
preparations from Chaetomorpha antennina and Aegiceras 
corniculatum against Plasmodium falciparum. Parasitology 
Research. 2011; 108 (1); 107-113.  
10. Palanisamy S, Sellappa S. Antioxidant and antibacterial 
properties of methanolic extract of green seaweed 
Chaetomorpha linum from Gulf of Mannar: Southeast coast of 
India. Jundishapur Journal of Microbiology, 2012; 12(2):411-
415. 
11. Maheswari MU, Reena A and Sivaraj C. GC-MS analysis, 
antioxidant and antibacterial activity of the brown algae, 
Padina tetrastromatica. International Journal of 
Pharmaceutical Sciences and Research, 2018; 9(1): 298-304. 
12. Edeoga HO, Okwu DE and Mbaebie BO. Phytochemical 
constituents of some Nigerian medicinal plants. African 
journal of biotechnology, 2005; 4(7): 685-688. 
13. Eloff JN. A sensitive and quick microplate method to 
determine the minimal inhibitory concentration of plant 
extracts for bacteria. Planta medica, 1998; 64(08): 711-713.. 
14. Sharma D, Narasimhan B, Kumar P, Judge V, Narang R, De 
Clercq E and Balzarini J. Synthesis, antimicrobial and antiviral 
evaluation of substituted imidazole derivatives. European 
journal of medicinal chemistry, 2009; 44(6): 2347-2353. 
15. Prakash S, Ahila NK, Ravikumar S and Kannapiran E. 
Phenotypic and genotypic probing of biofertilizing 
halotolerant Azospirillum spp. and Bacillus spp. Middle-East 
Journal of Scientific Research, 2013; 15(1); 128-133. 
16. Clinical and Laboratory Standards Institute (CLSI). Document 
M100-S24. Wayne, Pa, USA: CLSI; 2014. Performance 
standards for antimicrobial susceptibility testing; twenty-
forth informational supplement. 
17. Bazargani MM and Rohloff J. Antibiofilm activity of essential 
oils and plant extracts against Staphylococcus aureus and 
Escherichia coli biofilms. Food Control, 2016; 61: 156-164. 
18. Manikandan SS, Ganesapandian, M. Singh, N. Sangeetha and 
A.K. Kumaraguru. Antimicrobial activity of seaweeds against 
multi drug resistant strains. Int. J. Pharmacol. 2011; 7: 522-
526. 
19. Sivakumar SM, Safhi SM. Isolation and screening of bioactive 
principle from Chaetomorpha antennina against certain 
bacterial strains. Saudi Pharmaceutical Journal, 2013; 21, 
119–121. 
20. Subathraa K and Poonguzhali TV. Effect of different extracts of 
Chaetomorpha antennina and their phytochemical 
screening. Int J Curr Sci, 2013; 6: 35-39. 
21. Abhishek D, Jyoti P, Savan D and Sumitra C. Pharmacognostic 
standardization of chaetomorpha antennina and Ulva lactuca, 
green seaweeds from Gujarat coast Journal of Pharmacognosy 
and Phytochemistry, 2018: 7(2); 3863-3870. 
22. Lima-Filho JVM, Carvalho AF, Freitas SM and Melo VM. 
Antibacterial activity of extracts of six macroalgae from the 
northeastern Brazilian coast. Brazilian Journal of 
Microbiology, 2002; 33(4); 311-314. 
23. Latha PD and Hemalatha KPJ. Antimicrobial activity of the 
chloroform extracts of the chlorophycean seaweeds 
Enteromorpha comressa and Chaetomorpha antennina. Int. 
Res. J. Microbiol. 2011; 2(8): 249-252. 
24. Phillips I, Andrews JM, Bridson E, Cooke EM, Spencer RC, Holt 
HA, Wise R, Bint  J, Brown D. FJ,Greenwood, D, King A  and 
Williams RJ. A Guide to Sensitivity Testing. Report of the 
Working Party on Antibiotic Sensitivity Testing of the British 
Society for Antimicrobial Chemotherapy, 1991; 27: 1-50. 
25. Ertur   mer and Ta  Beyhan. Antibacterial and Antifungal 
Effects of Some Marine Algae.  af as U niversitesi Veteriner 
Fa u ltesi Dergisi. 2011; 17: S121-S124. 
26. Namasivayam SKR, Beninton B, Christo B, Karthigai SM, Arun 
Muthu Kumar K, Deepak K. Anti-biofilm effect of biogenic 
silver nanoparticles coated medical devices against biofilm of 
clinical isolate of Staphylococcus aureus. Global Journal of 
Medical Research. 2013; 13(3):1–7. 
27. Murugan A, Meera. RL, Raja P, Senthil KA. Antibacterial 
activity of the seaweed Chaetomorpha antennina and its 
epiphytic bacteria against biofilm and human pathogenic 
bacteria. Seaweed Research and Utilisation, 2007: 29 (1-2); 
67-74. 
28. Mubarak Z, Humaira A, Gani B.A and Muchlisin ZA. 
Preliminary study on the inhibitory effect of seaweed 
Gracilaria verrucosa extract on biofilm formation of Candida 
albicans cultured from the saliva of a smoker. F1000Research. 
2018; 7:684. 
 
